We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$869B
AUM Growth
+$32.9B
Cap. Flow
-$6.92B
Cap. Flow %
-0.8%
Top 10 Hldgs %
33.83%
Holding
3,059
New
82
Increased
1,782
Reduced
864
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$2.31B
2
AAPL icon
Apple
AAPL
+$1.58B
3
SHW icon
Sherwin-Williams
SHW
+$1.37B
4
HUBS icon
HubSpot
HUBS
+$1.32B
5
KVUE icon
Kenvue
KVUE
+$1.25B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.37B
2
LRCX icon
Lam Research
LRCX
+$1.54B
3
AMAT icon
Applied Materials
AMAT
+$1.33B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.19B
5
HAL icon
Halliburton
HAL
+$1.16B

Sector Composition

Rank Sector Weight
1 Technology 32.32%
2 Healthcare 15.15%
3 Financials 10.54%
4 Consumer Discretionary 10.48%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
1126
Diageo
DEO
$52.8B
$10.7M ﹤0.01%
75,893
+39,952
+111% +$5.19M
LENZ
1127
LENZ Therapeutics
LENZ
$145M
$10.7M ﹤0.01%
+448,631
New +$9.96M
HEI.A icon
1128
HEICO Corp Class A
HEI.A
$38B
$10.6M ﹤0.01%
51,873
+3,590
+7% +$681K
CNMD icon
1129
CONMED
CNMD
$1.49B
$10.5M ﹤0.01%
146,410
-34,600
-19% -$2.44M
MARA icon
1130
Marathon Digital Holdings
MARA
$3.56B
$10.5M ﹤0.01%
648,908
+499,695
+335% +$9.06M
TME icon
1131
Tencent Music
TME
$14.2B
$10.5M ﹤0.01%
868,081
-519,568
-37% -$6.36M
CHKP icon
1132
Check Point Software Technologies
CHKP
$13.7B
$10.5M ﹤0.01%
54,241
+32,745
+152% +$6M
PBR.A icon
1133
Petrobras Class A
PBR.A
$104B
$10.4M ﹤0.01%
788,153
FBIN icon
1134
Fortune Brands Innovations
FBIN
$5.83B
$10.3M ﹤0.01%
115,474
-82,037
-42% -$6.29M
TPL icon
1135
Texas Pacific Land
TPL
$23.9B
$10.3M ﹤0.01%
34,800
+2,274
+7% +$624K
BLMN icon
1136
Bloomin' Brands
BLMN
$924M
$10.2M ﹤0.01%
616,798
-316,820
-34% -$5.62M
ACAD icon
1137
Acadia Pharmaceuticals
ACAD
$4.89B
$10.2M ﹤0.01%
659,964
-260,122
-28% -$4.34M
LYEL icon
1138
Lyell Immunopharma
LYEL
$347M
$10.1M ﹤0.01%
367,614
-26,004
-7% -$764K
VERX icon
1139
Vertex
VERX
$2.15B
$9.82M ﹤0.01%
255,050
-1,800
-0.7% -$66.3K
PEGA icon
1140
Pegasystems
PEGA
$5.51B
$9.58M ﹤0.01%
262,096
+208,190
+386% +$6.86M
SONY icon
1141
Sony
SONY
$138B
$9.51M ﹤0.01%
+492,350
New +$8.97M
YMM icon
1142
Full Truck Alliance
YMM
$9.2B
$9.43M ﹤0.01%
1,046,489
-46,691
-4% -$358K
NWE icon
1143
NorthWestern Energy
NWE
$4.4B
$9.41M ﹤0.01%
164,529
+19,574
+14% +$1.05M
BIOA
1144
BioAge Labs
BIOA
$479M
$9.36M ﹤0.01%
+449,837
New +$9.01M
VRNS icon
1145
Varonis Systems
VRNS
$5.26B
$9.3M ﹤0.01%
164,661
+96,084
+140% +$5.05M
MASI
1146
DELISTED
Masimo
MASI
$9.3M ﹤0.01%
69,716
+1,427
+2% +$166K
ANRO icon
1147
Alto Neuroscience
ANRO
$1.26B
$9.25M ﹤0.01%
808,504
+162,672
+25% +$1.99M
BIO icon
1148
Bio-Rad Laboratories Class A
BIO
$9.68B
$9.24M ﹤0.01%
27,620
-17,730
-39% -$5.63M
NGG icon
1149
National Grid
NGG
$81.6B
$9.21M ﹤0.01%
+140,325
New +$8.6M
GGG icon
1150
Graco
GGG
$13.3B
$9.15M ﹤0.01%
104,511
+4,470
+4% +$367K

Similar funds

T. Rowe Price Associates's Q3 2024 Portfolio in Review

As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
  • T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
  • T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
  • T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.

Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.